1. Home
  2. PBT vs KALV Comparison

PBT vs KALV Comparison

Compare PBT & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Permian Basin Royalty Trust

PBT

Permian Basin Royalty Trust

HOLD

Current Price

$21.37

Market Cap

1.0B

Sector

Energy

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$20.39

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBT
KALV
Founded
1980
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
PBT
KALV
Price
$21.37
$20.39
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.60
AVG Volume (30 Days)
153.9K
1.1M
Earning Date
03-13-2026
05-09-2026
Dividend Yield
1.51%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$50,000,000.00
Revenue This Year
N/A
$187.19
Revenue Next Year
N/A
$54.93
P/E Ratio
$57.37
N/A
Revenue Growth
N/A
495.66
52 Week Low
$9.37
$9.83
52 Week High
$22.71
$21.31

Technical Indicators

Market Signals
Indicator
PBT
KALV
Relative Strength Index (RSI) 50.94 63.23
Support Level $19.81 $14.66
Resistance Level $22.71 $21.31
Average True Range (ATR) 0.91 1.37
MACD -0.11 0.04
Stochastic Oscillator 46.63 82.01

Price Performance

Historical Comparison
PBT
KALV

About PBT Permian Basin Royalty Trust

Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole, and others across Texas. The company earns the majority of its revenue in the form of royalties received through its properties.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: